Yang xin shi tablet enhances adaptability to exercise training by relieving statin-induced skeletal muscle injury

Chin Med J (Engl). 2020 Sep 20;133(18):2266-2268. doi: 10.1097/CM9.0000000000001028.

Authors

Ruo-Ming Wu¹, Bing Jiang^{2

3}, Hui Li², Wen-Zhen Dang², Cong Zhang⁴, Xiao-Zheng Zhong⁴, Yi Hong⁴, Guan Ye¹, Xiao-Yan Shen²

Affiliations

¹ Central Research Institute, Shanghai Pharmaceuticals Holding Co., Ltd., Shanghai 200120, China.
² Department of Pharmacology, School of Pharmacy, Fudan University, Shanghai 200120, China.
³ Department of Pharmacology of Chinese Materia Medica, School of Traditional Chinese Medicine, Guangdong Pharmaceutical University, Guangzhou, Guangdong 510006, China.
⁴ SPH Qingdao Growful Pharmaceutical Co., Ltd., Qingdao, Shandong 266510, China.

No abstract available

Publication types

Letter

MeSH terms

Drugs, Chinese Herbal
Exercise
Hydroxymethylglutaryl-CoA Reductase Inhibitors*
Muscle, Skeletal
Tablets

Substances

Drugs, Chinese Herbal
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Tablets
yang xin